TNF-α and IL-1α induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells

被引:133
作者
Terry, CM
Clikeman, JA
Hoidal, JR
Callahan, KS
机构
[1] Univ Utah, Dept Pharmacol & Toxicol, Div Pulm, Salt Lake City, UT 84132 USA
[2] Univ Utah, Dept Internal Med, Salt Lake City, UT 84132 USA
[3] Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1999年 / 276卷 / 05期
关键词
cytokine; phorbol; 12-myristate; 13-acetate; phosphatase; protein kinase C downregulation; protein kinase C isoforms; tumor necrosis factor-alpha; interleukin-1; alpha;
D O I
10.1152/ajpheart.1999.276.5.H1493
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heme oxygenase-1 (HO-1), an enzyme important in protection against oxidant stress, is induced in human vascular endothelial cells by the cytokines tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 alpha (IL-1 alpha). However, the signaling mediators that regulate the induction are not known. This study examined the involvement of protein kinase C (PKC), phospholipase A(2) (PLA(2)), calcium, and oxidants in cytokine induction of HO-1. Acute exposure to the PKC activator phorbol 12-myristate 13-acetate (PMA) stimulated HO-1 mRNA. However, prolonged exposure, which downregulates most PKC isoforms, blocked induction of HO-1 mRNA by IL-1 alpha and TNF-alpha. Additionally, the phosphatase inhibitors okadaic acid and calyculin enhanced cytokine induction of HO-1. Mepacrine, a PLA(2) inhibitor, prevented HO-1 induction by cytokine, suggesting a role for arachidonate, the product of PLA(2) hydrolysis of phospholipids, in HO-1 expression. The intracellular calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester (BAPTA-AM) blocked cytokine induction of HO-1. Paradoxically, the calcium ionophore A-23187 prevented HO-1 induction by cytokine but not by PMA. Finally, the oxidant scavenger N-acetylcysteine inhibited HO-1 induction by cytokines. These results demonstrate that TNF-alpha and IL-1 alpha induction of HO-1 requires PKC-mediated phosphorylation and PLA(2) activation as well as oxidant generation.
引用
收藏
页码:H1493 / H1501
页数:9
相关论文
共 64 条
[41]  
MURPHY HS, 1992, AM J PHYSIOL, V263, P51
[42]   INDUCTION OF HEME OXYGENASE IS A RAPID, PROTECTIVE RESPONSE IN RHABDOMYOLYSIS IN THE RAT [J].
NATH, KA ;
BALLA, G ;
VERCELLOTTI, GM ;
BALLA, J ;
JACOB, HS ;
LEVITT, MD ;
ROSENBERG, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :267-270
[43]   Heme oxygenase-1 gene expression by a glutathione depletor, phorone, mediated through AP-1 activation in rats [J].
Oguro, T ;
Hayashi, M ;
Numazawa, S ;
Asakawa, K ;
Yoshida, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (02) :259-265
[44]   HEMOGLOBIN PROVIDES PROTECTION AGAINST LETHAL ENDOTOXEMIA IN RATS - THE ROLE OF HEME OXYGENASE-1 [J].
OTTERBEIN, L ;
SYLVESTER, SL ;
CHOI, AMK .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 13 (05) :595-601
[45]   TNF-ALPHA INDUCES PEROXYNITRITE-MEDIATED DEPLETION OF LUNG ENDOTHELIAL GLUTATHIONE VIA PROTEIN-KINASE-C [J].
PHELPS, DT ;
FERRO, TJ ;
HIGGINS, PJ ;
SHANKAR, R ;
PARKER, DM ;
JOHNSON, A .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 269 (04) :L551-L559
[46]   Phospholipid peroxidation induces cytosolic phospholipase A(2) activity: Membrane effects versus enzyme phosphorylation [J].
RashbaStep, J ;
Tatoyan, A ;
Duncan, R ;
Ann, D ;
PushpaRehka, TR ;
Sevanian, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 343 (01) :44-54
[47]  
RITCHIE AJ, 1991, J IMMUNOL, V146, P3056
[48]   REACTIVE OXYGEN INTERMEDIATES AS APPARENTLY WIDELY USED MESSENGERS IN THE ACTIVATION OF THE NF-KAPPA-B TRANSCRIPTION FACTOR AND HIV-1 [J].
SCHRECK, R ;
RIEBER, P ;
BAEUERLE, PA .
EMBO JOURNAL, 1991, 10 (08) :2247-2258
[49]  
SCHUGER L, 1989, LAB INVEST, V61, P62
[50]   TUMOR-NECROSIS-FACTOR INDUCES RAPID PRODUCTION OF 1'2'DIACYLGLYCEROL BY A PHOSPHATIDYLCHOLINE-SPECIFIC PHOSPHOLIPASE-C [J].
SCHUTZE, S ;
BERKOVIC, D ;
TOMSING, O ;
UNGER, C ;
KRONKE, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (05) :975-988